Blog

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

TransMedics (TMDX) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TMDX broke out above the 50-day moving average

Dun & Bradstreet (DNB) reported $585.2 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 1.6%. EPS of $0.19 for the same period compares to $0.23 a year

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

RADCOM Ltd. (RDCM) is slated to report second-quarter 2025 results on Aug. 13, before market open.

The Zacks Consensus Estimate for revenues is $17 million, suggesting 14.9% growth from the

Curtiss-Wright Corp. CW benefits from rising commercial nuclear aftermarket sales and consistent shareholder-focused initiatives that have played a pivotal role in strengthening the company’s

Green Dot Corporation GDOT reported impressive second-quarter 2025 results, wherein both earnings and revenues beat the Zacks Consensus Estimate.

Quarterly earnings per share (excluding $1.25 from

Have you evaluated the performance of Lam Research's (LRCX) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this

A strong stock as of late has been Puma Biotech (PBYI). Shares have been marching higher, with the stock up 40.6% over the past month. The stock hit a new 52-week high of $5.06 in the previous

Have you assessed how the international operations of MKS (MKSI) performed in the quarter ended June 2025? For this maker of analysis and processing equipment for semiconductor companies, possessing

Have you evaluated the performance of Watts Water's (WTS) international operations during the quarter that concluded in June 2025? Considering the extensive worldwide presence of this maker of

Have you been paying attention to shares of Xeris Biopharma (XERS)? Shares have been on the move with the stock up 32.4% over the past month. The stock hit a new 52-week high of $7.61 in the

Here's a revealing data point: older Americans are scared more of outliving wealth than of death itself.

And older Americans have legitimate reasons for this worry, even if they have dutifully saved

Strange but true: seniors fear death less than running out of money in retirement.

Also, retirees who have constructed a nest egg have valid justifications to be concerned, since the traditional

GoPro, Inc. GPRO reported second-quarter 2025 non-GAAP loss per share of 8 cents, wider than the Zacks Consensus Estimate of a loss of 7 cents.  This came within the company’s forecast of non-GAAP

The Trade Desk TTD stock has tumbled 39.8% following the release of its second-quarter 2025 earnings on Aug. 7. Revenues increased 19% year over year to $694 billion and beat the consensus mark by

Major indexes on Wall Street have hit multiple new all-time closing highs over the past month. However, stocks have shown volatility over the past couple of weeks, disrupting the rally. The ongoing